400 related articles for article (PubMed ID: 23210518)
1. Designing enzyme-like catalysts: a rhodium(II) metallopeptide case study.
Ball ZT
Acc Chem Res; 2013 Feb; 46(2):560-70. PubMed ID: 23210518
[TBL] [Abstract][Full Text] [Related]
2. Sequence-specific inhibition of a designed metallopeptide catalyst.
Popp BV; Chen Z; Ball ZT
Chem Commun (Camb); 2012 Aug; 48(60):7492-4. PubMed ID: 22728748
[TBL] [Abstract][Full Text] [Related]
3. Beyond the Second Coordination Sphere: Engineering Dirhodium Artificial Metalloenzymes To Enable Protein Control of Transition Metal Catalysis.
Lewis JC
Acc Chem Res; 2019 Mar; 52(3):576-584. PubMed ID: 30830755
[TBL] [Abstract][Full Text] [Related]
4. Design of biomimetic catalysts by molecular imprinting in synthetic polymers: the role of transition state stabilization.
Wulff G; Liu J
Acc Chem Res; 2012 Feb; 45(2):239-47. PubMed ID: 21967389
[TBL] [Abstract][Full Text] [Related]
5. Molecular recognition in protein modification with rhodium metallopeptides.
Ball ZT
Curr Opin Chem Biol; 2015 Apr; 25():98-102. PubMed ID: 25588960
[TBL] [Abstract][Full Text] [Related]
6. Screening rhodium metallopeptide libraries "on bead": asymmetric cyclopropanation and a solution to the enantiomer problem.
Sambasivan R; Ball ZT
Angew Chem Int Ed Engl; 2012 Aug; 51(34):8568-72. PubMed ID: 22777868
[TBL] [Abstract][Full Text] [Related]
7. Helix induction by dirhodium: access to biocompatible metallopeptides with defined secondary structure.
Zaykov AN; Popp BV; Ball ZT
Chemistry; 2010 Jun; 16(22):6651-9. PubMed ID: 20411535
[TBL] [Abstract][Full Text] [Related]
8. Studies of asymmetric styrene cyclopropanation with a rhodium(II) metallopeptide catalyst developed with a high-throughput screen.
Sambasivan R; Ball ZT
Chirality; 2013 Sep; 25(9):493-7. PubMed ID: 23749505
[TBL] [Abstract][Full Text] [Related]
9. Artificial metalloenzymes via encapsulation of hydrophobic transition-metal catalysts in surface-crosslinked micelles (SCMs).
Zhang S; Zhao Y
Chem Commun (Camb); 2012 Oct; 48(80):9998-10000. PubMed ID: 22935642
[TBL] [Abstract][Full Text] [Related]
10. Enzyme Activity by Design: An Artificial Rhodium Hydroformylase for Linear Aldehydes.
Jarvis AG; Obrecht L; Deuss PJ; Laan W; Gibson EK; Wells PP; Kamer PCJ
Angew Chem Int Ed Engl; 2017 Oct; 56(44):13596-13600. PubMed ID: 28841767
[TBL] [Abstract][Full Text] [Related]
11. A Hexa-rhodium Metallopeptide Catalyst for Site-Specific Functionalization of Natural Antibodies.
Ohata J; Ball ZT
J Am Chem Soc; 2017 Sep; 139(36):12617-12622. PubMed ID: 28810739
[TBL] [Abstract][Full Text] [Related]
12. Bioinspired catalyst design and artificial metalloenzymes.
Deuss PJ; den Heeten R; Laan W; Kamer PC
Chemistry; 2011 Apr; 17(17):4680-98. PubMed ID: 21480401
[TBL] [Abstract][Full Text] [Related]
13. Site-specific protein modification with a dirhodium metallopeptide catalyst.
Chen Z; Popp BV; Bovet CL; Ball ZT
ACS Chem Biol; 2011 Sep; 6(9):920-5. PubMed ID: 21671614
[TBL] [Abstract][Full Text] [Related]
14. Directed Evolution of Artificial Metalloenzymes: A Universal Means to Tune the Selectivity of Transition Metal Catalysts?
Reetz MT
Acc Chem Res; 2019 Feb; 52(2):336-344. PubMed ID: 30689339
[TBL] [Abstract][Full Text] [Related]
15. Supramolecular bidentate ligands by metal-directed in situ formation of antiparallel beta-sheet structures and application in asymmetric catalysis.
Laungani AC; Slattery JM; Krossing I; Breit B
Chemistry; 2008; 14(15):4488-502. PubMed ID: 18449870
[TBL] [Abstract][Full Text] [Related]
16. Catalytic protein modification with dirhodium metallopeptides: specificity in designed and natural systems.
Chen Z; Vohidov F; Coughlin JM; Stagg LJ; Arold ST; Ladbury JE; Ball ZT
J Am Chem Soc; 2012 Jun; 134(24):10138-45. PubMed ID: 22621321
[TBL] [Abstract][Full Text] [Related]
17. Chemical Posttranslational Modification with Designed Rhodium(II) Catalysts.
Martin SC; Minus MB; Ball ZT
Methods Enzymol; 2016; 580():1-19. PubMed ID: 27586326
[TBL] [Abstract][Full Text] [Related]
18. Metallopeptide catalysts and artificial metalloenzymes containing unnatural amino acids.
Lewis JC
Curr Opin Chem Biol; 2015 Apr; 25():27-35. PubMed ID: 25545848
[TBL] [Abstract][Full Text] [Related]
19. Rhodium(II) metallopeptide catalyst design enables fine control in selective functionalization of natural SH3 domains.
Vohidov F; Coughlin JM; Ball ZT
Angew Chem Int Ed Engl; 2015 Apr; 54(15):4587-91. PubMed ID: 25688989
[TBL] [Abstract][Full Text] [Related]
20. Femtomolar Zn(II) affinity in a peptide-based ligand designed to model thiolate-rich metalloprotein active sites.
Petros AK; Reddi AR; Kennedy ML; Hyslop AG; Gibney BR
Inorg Chem; 2006 Dec; 45(25):9941-58. PubMed ID: 17140191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
